KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to -$54.5 million.

  • Gsk's Exchange Rate Effect fell 13631.32% to -$54.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$23.5 million, marking a year-over-year decrease of 13270.09%. This contributed to the annual value of -$25.1 million for FY2025, which is 6370.12% up from last year.
  • According to the latest figures from Q4 2025, Gsk's Exchange Rate Effect is -$54.5 million, which was down 13631.32% from $79.6 million recorded in Q3 2025.
  • In the past 5 years, Gsk's Exchange Rate Effect ranged from a high of $687.6 million in Q4 2023 and a low of -$1.8 billion during Q4 2022
  • Moreover, its 5-year median value for Exchange Rate Effect was -$12.0 million (2024), whereas its average is -$54.1 million.
  • Over the last 5 years, Gsk's Exchange Rate Effect had its largest YoY gain of 629690.2% in 2022, and its largest YoY loss of 381809.0% in 2022.
  • Gsk's Exchange Rate Effect (Quarter) stood at -$45.8 million in 2021, then tumbled by 3818.09% to -$1.8 billion in 2022, then skyrocketed by 138.29% to $687.6 million in 2023, then tumbled by 78.16% to $150.2 million in 2024, then tumbled by 136.31% to -$54.5 million in 2025.
  • Its Exchange Rate Effect was -$54.5 million in Q4 2025, compared to $79.6 million in Q3 2025 and -$34.7 million in Q2 2025.